Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike.

TitleEnhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike.
Publication TypeJournal Article
Year of Publication2021
AuthorsDerking R, Allen JD, Cottrell CA, Sliepen K, Seabright GE, Lee W-H, Aldon Y, Rantalainen K, Antanasijevic A, Copps J, Yasmeen A, Cupo A, Portillo VMCruz, Poniman M, Bol N, van der Woude P, de Taeye SW, van den Kerkhof TLGM, Klasse PJ, Ozorowski G, van Gils MJ, Moore JP, Ward AB, Crispin M, Sanders RW
JournalCell Rep
Volume35
Issue1
Pagination108933
Date Published2021 Apr 06
ISSN2211-1247
KeywordsAnimals, CHO Cells, Cricetulus, Cryoelectron Microscopy, env Gene Products, Human Immunodeficiency Virus, Glycosylation, HEK293 Cells, Hexosyltransferases, HIV-1, Humans, Membrane Proteins, Models, Molecular, Polysaccharides, Protein Multimerization, Solubility
Abstract

Artificial glycan holes on recombinant Env-based vaccines occur when a potential N-linked glycosylation site (PNGS) is under-occupied, but not on their viral counterparts. Native-like SOSIP trimers, including clinical candidates, contain such holes in the glycan shield that induce strain-specific neutralizing antibodies (NAbs) or non-NAbs. To eliminate glycan holes and mimic the glycosylation of native BG505 Env, we replace all 12 NxS sequons on BG505 SOSIP with NxT. All PNGS, except N133 and N160, are nearly fully occupied. Occupancy of the N133 site is increased by changing N133 to NxS, whereas occupancy of the N160 site is restored by reverting the nearby N156 sequon to NxS. Hence, PNGS in close proximity, such as in the N133-N137 and N156-N160 pairs, affect each other's occupancy. We further apply this approach to improve the occupancy of several Env strains. Increasing glycan occupancy should reduce off-target immune responses to vaccine antigens.

DOI10.1016/j.celrep.2021.108933
Alternate JournalCell Rep
PubMed ID33826885
PubMed Central IDPMC8804554
Grant ListF31 AI131873 / AI / NIAID NIH HHS / United States
P01 AI110657 / AI / NIAID NIH HHS / United States
UM1 AI100663 / AI / NIAID NIH HHS / United States
UM1 AI144462 / AI / NIAID NIH HHS / United States

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587